Iris Ventures, a Barcelona-based growth investor focused on purpose-led consumer brands, has announced the first close of €100 million for its second fund, IRIS Fund II, which targets a total of €200 million. The new fund will invest in companies across beauty, wellness, nutrition, longevity, and conscious living.
Founded in 2021 by Montse Suarez, Iris Ventures supports brands that merge commercial performance with strong values. “Innovation doesn’t only come from technology, it also comes from how people live, consume, and care for themselves and the planet” Suarez said. “We champion founders determined to grow responsibly and shape a more inclusive, regenerative economy.”
The firm’s first €100 million fund backed companies including Olistic, VICIO, Essentialist, Superlativa, Maurten, Healf, and Artemest, brands that blend purpose with scalable growth. Iris Ventures typically invests €5 million to €20 million per company, supporting 12 to 15 scale-ups over a four-year period.
Around 80% of IRIS Fund II will be allocated to European startups, with the remainder directed toward U.S. companies that align with its mission. The fund’s investor base includes European family offices with deep roots in consumer industries, offering both capital and strategic guidance.
Unlike traditional private equity firms, Iris Ventures operates through a partnership model, working closely with founders on scaling, brand strategy, and international growth. This approach combined with patient capital, has positioned the firm as one of Europe’s emerging leaders in purpose-driven consumer growth investing.
The launch of IRIS Fund II comes amid rising global demand for ethical, wellness-focused, and sustainable brands, as consumers increasingly prioritize transparency and wellbeing. Iris Ventures aims to bridge the gap between Europe’s growing lifestyle sector and the more mature U.S. market, helping founders scale without sacrificing their brand’s mission or authenticity.
